OncoOne reposted this
OncoOne’s PreTarg-it® Platform shines on the cover of Molecular Cancer Therapeutics! Our platform for pre-targeted radioimmunotherapy is featured as the First Disclosure and cover story in this month’s AACR journal Molecular Cancer Therapeutics (MCT). Our innovative two-step regimen is set to revolutionize the delivery of radioactive payloads in cancer treatment. #OncoOne #PreTargit #CancerResearch #Radioimmunotherapy #AACR #radiopharmaceuticals #theranostic Discover more about our findings here: https://lnkd.in/eNZAM6jE
